By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Implicity scores €35M to carry its cardiac-device AI into the US
    By
    msadmin
    September 9, 2026
    GenHealth.ai banks $16.5M for billing agents trained on 140M patients
    By
    msadmin
    September 9, 2026
    Forus triples value to $3B on a $150M Bain-led round
    By
    msadmin
    September 9, 2026
    DeepMind publishes free atlas scoring every DNA letter change
    By
    msadmin
    September 9, 2026
    Harrison.ai trims Australian staff to fund US AI radiology push
    By
    msadmin
    September 9, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
    Teladoc puts 100 percent of fees at risk with new AI-powered platform
    By
    msadmin
    July 27, 2026
    Johns Hopkins finds frontier AI agents fail most complex health tasks
    By
    msadmin
    July 27, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

DeepMind publishes free atlas scoring every DNA letter change

DeepMind's open AlphaGenome Atlas maps how all nine billion possible single-letter DNA changes could matter.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: September 9, 2026
Share
2 Min Read
SHARE

Google DeepMind has turned its DNA model into an open map of the human genome. The AlphaGenome Atlas, released September 8, predicts the effects of all nine billion possible single-letter DNA changes and serves them up through a searchable, one-petabyte resource that requires no coding skills.

The atlas is built on AlphaGenome, the model DeepMind launched last year. Roughly 9,000 researchers have already pulled variant predictions through its programming interface, but product manager Dhavi Hariharan says writing code kept many biologists away. The new format lets scientists browse results the way they would flip through a physical atlas.

Each entry now carries a single AlphaGenome Variant Impact (AVI) score that ranks how much a change is likely to matter. In a test with the GREGoR Consortium, the scores flagged a variant in the DNM1 gene linked to a severe childhood brain disorder and pointed to the mechanism: the change created an incorrect splice site that lengthened the resulting protein. DeepMind and academic partners, including the Broad Institute, describe the work in a preprint released alongside the atlas.

The resource also covers more than 100 million short insertions and deletions seen in human genomes. DeepMind modeled the effort on its AlphaFold database, whose protein predictions have been used by millions of researchers, and offers the atlas free for non-commercial use.

Scientists caution that the scores are predictions, not verdicts. Martin Kircher of the Max Delbruck Center for Molecular Medicine in Berlin says the atlas will not replace experiments or individual-level diagnosis, calling it a useful and generous way to scale access to a strong model.

TAGGED:AlphaGenomeDeepMindDNA variantsGenomicsopen sciencePrecision Medicinerare disease
SOURCES:NatureThe Register
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

AI-Powered Skin Cancer Tool DERM Rolls Out in Barking & Dagenham to Cut Wait Times and Boost Early Detection

By
Yu Chi Huang
June 24, 2025
News & Alerts

Epic’s image exchange moves full scans between hospitals

By
msadmin
August 16, 2026
News & Alerts

Tempus AI acquires Personalis for $1.5B in precision medicine play

By
msadmin
July 22, 2026
News & Alerts

Innovaccer and Mastek pair up to ship agentic AI abroad

By
msadmin
August 16, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal